Preliminary results from the use of the novel Interactive Binocular Treatment (I-BiT™) system, in the treatment of strabismic and anisometropic amblyopia

被引:65
|
作者
Waddingham, PE
Butler, TKH
Cobb, SV
Moody, ADR
Comaish, IF
Haworth, SM
Gregson, RM
Ash, IM
Brown, SM
Eastgate, RM
Griffiths, GD
机构
[1] Univ Nottingham, Sch 4M, VIRART, Nottingham NG7 2RD, England
[2] Univ Nottingham Hosp, Queens Med Ctr, Directorate Ophthalmol, Eye Ear Nose & Throat Ctr, Nottingham NG7 2UH, England
关键词
amblyopia; binocular treatment; virtual reality (VR); games;
D O I
10.1038/sj.eye.6701883
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background We have developed a novel application of adapted virtual reality (VR) technology, for the binocular treatment of amblyopia. We describe the use of the system in six children. Methods Subjects consisted of three conventional treatment 'failures' and three conventional treatment 'refusers', with a mean age of 6.25 years ( 5.42 - 7.75 years). Treatment consisted of watching video clips and playing interactive games with specifically designed software to allow streamed binocular image presentation. Results Initial vision in the amblyopic eye ranged from 6/12 to 6/120 and post-treatment 6/7.5 to 6/24-1. Total treatment time was a mean of 4.4 h. Five out of six children have shown an improvement in their vision ( average increase of 10 letters), including those who had previously failed to comply with conventional occlusion. Conclusions Improvements in vision were demonstrable within a short period of time, in some children after 1 h of treatment. This system is an exciting and promising application of VR technology as a new treatment for amblyopia.
引用
收藏
页码:375 / 378
页数:4
相关论文
共 50 条
  • [21] SOME RESULTS FROM THE USE OF RADIOACTIVE IODINE, I-131, IN THE DIAGNOSIS AND TREATMENT OF TOXIC GOITER
    WERNER, SC
    GOODWIN, LD
    QUIMBY, EH
    SCHMIDT, C
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1950, 63 (06) : 889 - 894
  • [22] Preliminary Results of a Phase I-II Clinical Trial on the Use of Bone Marrow Mononuclear Cells in the Treatment of Amyotrophic Lateral Sclerosis
    Blanquer, M.
    Iniesta, F.
    Ruiz, F. R.
    Meca, J.
    Espuch, J. Gomez
    Villaverde, R.
    Santos, J. M. Garcia
    del Rio, S. Torres
    Funes, C.
    Izura, V.
    Casado, P. de Mingo
    Salinas, A. Sanchez
    Saez, V.
    Carles, R.
    Antunez, C.
    Moreau, L. Vivancos
    Palazon, J. Hernandez
    Bleda, P.
    Majado, M. J.
    Espejo, M. A. Perez
    Martinez, S.
    Moraleda, J. M.
    HUMAN GENE THERAPY, 2009, 20 (09) : 1036 - 1036
  • [23] Preliminary Results of the Impact of the Use of Pillbox on the Stabilization of the INR among Patients Initiating Warfarin Treatment from a Prospective Cohort
    Dumas, Stephanie
    Rouleau-Mailloux, Etienne
    Dube, Marie-Pierre
    Tardif, Jean-Claude
    Talajic, Mario
    Perreault, Sylvie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 462 - 462
  • [24] Novel Neuromodulation Treatment Using Repetitive Magnetic Stimulation for Diabetic Gastroparesis: Preliminary Results From a Proof-of-Concept Study
    Sharma, Amol
    Karunaratne, Tennekoon B.
    Yan, Yun
    Eubanks, Audrey
    Inman, Brooke
    Rao, Satish
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S661 - S661
  • [25] CHARACTERISTICS OF UNTREATED SLEEP DISTURBANCE DURING INTENSIVE OUTPATIENT TREATMENT FOR SUBSTANCE USE DISORDERS: PRELIMINARY RESULTS FROM A LONGITUDINAL STUDY
    Wilkerson, A. K.
    Taylor, D. J.
    Sahlem, G. L.
    Simmons, R. O.
    Russell, A.
    Book, S. W.
    Smith, J. P.
    Uhde, T. W.
    McRae-Clark, A. L.
    SLEEP, 2020, 43 : A422 - A422
  • [26] A Novel Approach to Defining Success in the Acute Treatment of Migraine: Pooled Results From the ACHIEVE I and ACHIEVE II Trials
    Iaconangelo, C.
    Serrano, D.
    Adams, A. Manack
    Trugman, J. M.
    Lipton, R. B.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 97 - 97
  • [27] A novel approach to defining success in the acute treatment of migraine: Pooled results from the ACHIEVE I and ACHIEVE II trials
    Iaconangelo, C.
    Serrano, D.
    Adams, Manack A.
    Trugman, J. M.
    Lipton, R. B.
    HEADACHE, 2021, 61 : 90 - 91
  • [28] Novel intraperitoneal treatment for peritoneal metastases: results from the Immunotoxin in Peritoneal Carcinomatosis (ImmunoPeCa) phase I clinical trial
    Flatmark, Kjersti
    Andersson, Yvonne
    Davidson, Ben
    Dueland, Svein
    Fodstad, Oystein
    Froysnes, Ida S.
    Giercksky, Karl Erik
    Julsrud, Lars
    Larsen, Stein G.
    Olsen, Kari H.
    Oien, Janne M. T.
    CANCER RESEARCH, 2016, 76
  • [29] A Novel Approach to Defining Success in the Acute Treatment of Migraine: Pooled Results From the ACHIEVE I and ACHIEVE II Trials
    Iaconangelo, Charles
    Serrano, Daniel
    Adams, Aubrey Manack
    Trugman, Joel M.
    Lipton, Richard B.
    NEUROLOGY, 2021, 96 (15)
  • [30] A Novel Approach to Defining Success in the Acute Treatment of Migraine: Pooled Results From the ACHIEVE I and ACHIEVE II Trials
    Iaconangelo, C.
    Serrano, D.
    Adams, A. Manack
    Trugman, J. M.
    Lipton, R. B.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 144 - 144